RT @DhirajGuptaBHRS: The Pivotal randomised PRAGUE-17 trial showing equivalence of LAAC with NOAC in high-risk AF patients published in @JA…
RT @bernardowise: Left Atrial Appendage Closure May Be Noninferior Compared To Direct Oral Anticoagulants In Patients With #AFib At High Ri…
Left Atrial Appendage Closure May Be Noninferior Compared To Direct Oral Anticoagulants In Patients With #AFib At High Risk For Stroke #EPeeps https://t.co/r7Q1uWVcDn
RT @DFCapodanno: Kudos to the investigators, but this is one of those cases where noninferiority is not enough. Noninferiority makes sense…
RT @DFCapodanno: Kudos to the investigators, but this is one of those cases where noninferiority is not enough. Noninferiority makes sense…
RT @DFCapodanno: Kudos to the investigators, but this is one of those cases where noninferiority is not enough. Noninferiority makes sense…
Otra sobre oclusor de orejuela izquierda
Great insight! @LuisCLCorreia
RT @DFCapodanno: Kudos to the investigators, but this is one of those cases where noninferiority is not enough. Noninferiority makes sense…
RT @DFCapodanno: Kudos to the investigators, but this is one of those cases where noninferiority is not enough. Noninferiority makes sense…
RT @DFCapodanno: Kudos to the investigators, but this is one of those cases where noninferiority is not enough. Noninferiority makes sense…
RT @DhirajGuptaBHRS: The Pivotal randomised PRAGUE-17 trial showing equivalence of LAAC with NOAC in high-risk AF patients published in @JA…
RT @DFCapodanno: Kudos to the investigators, but this is one of those cases where noninferiority is not enough. Noninferiority makes sense…
Kudos to the investigators, but this is one of those cases where noninferiority is not enough. Noninferiority makes sense if there is an advantage, which is not the case here. It's like designing a noninferiority study of PCI vs. GDMT: what's the use? http
Intentando entender el estudio PRAGUE 17. https://t.co/12nZBRQ2ZX
RT @Susumu_Manabe: 出血既往のあるリスクの高い心房細動患者では、カテーテル的左心耳閉鎖が抗凝固療法( DOAC)と同等の治療効果を有する。無作為化比較試験の結果。https://t.co/uO54Ap4l1l https://t.co/x625w2lYUd
信仰宗教はないのだが なぜ神は左心耳を人間に与えられたのだろうか
RT @Susumu_Manabe: 出血既往のあるリスクの高い心房細動患者では、カテーテル的左心耳閉鎖が抗凝固療法( DOAC)と同等の治療効果を有する。無作為化比較試験の結果。https://t.co/uO54Ap4l1l https://t.co/x625w2lYUd
RT @Susumu_Manabe: 出血既往のあるリスクの高い心房細動患者では、カテーテル的左心耳閉鎖が抗凝固療法( DOAC)と同等の治療効果を有する。無作為化比較試験の結果。https://t.co/uO54Ap4l1l https://t.co/x625w2lYUd
RT @DhirajGuptaBHRS: The Pivotal randomised PRAGUE-17 trial showing equivalence of LAAC with NOAC in high-risk AF patients published in @JA…
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation https://t.co/jSdSwJ9QEg
PRAGUE 17 Cierre de orejuela en FANV, historia de sangrado o evento embólico o alto riesgo de trombosis/sangrado. Cumple criterio de no inferioridad comparado a DOAC. https://t.co/12nZBRQ2ZX
RT @DhirajGuptaBHRS: The Pivotal randomised PRAGUE-17 trial showing equivalence of LAAC with NOAC in high-risk AF patients published in @JA…
RT @DhirajGuptaBHRS: The Pivotal randomised PRAGUE-17 trial showing equivalence of LAAC with NOAC in high-risk AF patients published in @JA…
RT @DhirajGuptaBHRS: The Pivotal randomised PRAGUE-17 trial showing equivalence of LAAC with NOAC in high-risk AF patients published in @JA…
The Pivotal randomised PRAGUE-17 trial showing equivalence of LAAC with NOAC in high-risk AF patients published in @JACCJournals https://t.co/Rbp1Icm63u An excellent editorial by @docsaw puts it in context with previous and upcoming trials. https://t.co
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation | JACC: Journal of the American College of Cardiology https://t.co/eueAtRa9Kz
RT @DocCards: Timely article regarding Left Atrial Closure debate . “Among patients at high risk for stroke/bleeding, LAAC was noninferior…
Timely article regarding Left Atrial Closure debate . “Among patients at high risk for stroke/bleeding, LAAC was noninferior to DOAC in preventing AF-related cardiovascular, neurological, and bleeding events” Will be discussed at CME webinar June24,9 pmET
@bloodpure_bot 【左心耳閉鎖デバイス vs. DOAC:RCT/ JACC】 OAC適応があり大出血/塞栓イベント既往を有するAF 402例ランダム化、19.9カ月観察:デバイス群の「塞栓症・CV死亡・要処置出血・デバイス合併症」 発生率は10.99%。DAOC群 [13.42%] と有意差なく、非劣性。 https://t.co/4ZU0l359GX https://t.co/kdKI9Hcw0C
RT @Susumu_Manabe: 出血既往のあるリスクの高い心房細動患者では、カテーテル的左心耳閉鎖が抗凝固療法( DOAC)と同等の治療効果を有する。無作為化比較試験の結果。https://t.co/uO54Ap4l1l https://t.co/x625w2lYUd
In patients with Afib with a CHADS2VASC ~5, left atrial appendage closure had similar stroke/TIA, CV, and bleeding outcomes. Share your thoughts on the increasing use of LAAO devices in these patients! Will we start using LAOO instead of anticoagulation? h
Interested to hear @drjohnm thoughts..! https://t.co/3MpcCpzA7C
出血既往のあるリスクの高い心房細動患者では、カテーテル的左心耳閉鎖が抗凝固療法( DOAC)と同等の治療効果を有する。無作為化比較試験の結果。https://t.co/uO54Ap4l1l https://t.co/x625w2lYUd